Post-approval studies with the CFTR modulators Elexacaftor-Tezacaftor-Ivacaftor. [PDF]
Tümmler B.
europepmc +1 more source
CFTR Modulators for the Treatment of Chronic Obstructive Pulmonary Disease: The Jury Is Still Out! [PDF]
Regard L, Burgel PR.
europepmc +1 more source
Clinical pharmacology of CFTR modulators
With the development of cystic fibrosis transmembrane receptor (CFTR) modulating drugs, the landscape in cystic fibrosis (CF) care has changed dramatically. These drugs enable the treatment of the underlying cause of the disease. Although CFTR modulators show an impressive clincal effect at group level in people with CF (pwCF) with specific mutations ...
Meer - van de Grint, Renske van der +2 more
openaire +1 more source
Pseudomonas infections persisting after CFTR modulators are widespread throughout the lungs and drive lung inflammation. [PDF]
Durfey SL +25 more
europepmc +1 more source
Modeling Cystic Fibrosis Patient-Specific Responses to CFTR Modulators Using Human Induced Pluripotent Stem Cells. [PDF]
Kanagarajah KR +9 more
europepmc +1 more source
Comparative efficacy and safety of CFTR modulators for people with cystic fibrosis with phe508del mutation: a systematic review and bayesian network meta-analysis. [PDF]
Safeer V S M +7 more
europepmc +1 more source
Improvement of Cystic Fibrosis-Associated Liver Disease in Adults on Long-Term Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators. [PDF]
Manioudaki S +11 more
europepmc +1 more source
Progress of personalized medicine of cystic fibrosis in the times of efficient CFTR modulators. [PDF]
Tümmler B +6 more
europepmc +1 more source
A new era of cystic fibrosis therapy with CFTR modulators. [PDF]
Barros LGB +4 more
europepmc +1 more source
Impact of CFTR Modulators on Longitudinal Cystic Fibrosis Survival and Mortality: Review and Secondary Analysis. [PDF]
Rubin JL +5 more
europepmc +1 more source

